| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 臺大學術典藏 |
2020-09-29T16:47:19Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, YW; Tsai, CH; Lin, CC; Tien, FM; Chen, YW; HSIN-YI LIN; Yao, M; Lin, YC; Lin, CT; Cheng, CL; Tang, JL; Chou, WC; Hou, HA; Tien, HF |
| 臺大學術典藏 |
2020-10-28T08:35:05Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; CHENG-HONG TSAI; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F.; Yao M.; Lin H.-Y. |
| 臺大學術典藏 |
2020-12-09T00:46:09Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Lin, Chien-Chin; Tien, Feng-Ming; Chen, Yu-Wen; Lin, Hsing-Yu; MING YAO; Lin, Yun-Chu; Lin, Chien-Ting; Chieh-Lung Cheng; Tang, Jih-Luh; Chou, Wen-Chien; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Hou H.-A.; Chou W.-C.; Tang J.-L.; Cheng C.-L.; Lin C.-T.; Lin Y.-C.; MING YAO; Lin H.-Y.; Chen Y.-W.; Tien F.-M.; Lin C.-C.; Tsai C.-H.; Wang Y.-W.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; TIEN FENG-MING; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; JIH-LUH TANG; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.;Tsai C.-H.;Lin C.-C.;Tien F.-M.;Chen Y.-W.;Lin H.-Y.;Yao M.;Lin Y.-C.;Lin C.-T.;Cheng C.-L.;Tang J.-L.;Wen-Chien Chou;Hou H.-A.;Tien H.-F.; Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; WEN-CHIEN CHOU; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; FENG-MING TIEN; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 國立臺灣大學 |
2006 |
Cytogenetics in Childhood Acute Lymphoblastic Leukemia in Taiwan: A Single-Institutional Experience
|
張修豪; 盧孟佑; 周獻堂; 林凱信; 林東燦; 田蕙芬; CHANG, HSIU-HAO; LU, MENG-YAO; JOU, SHIANN-TARNG; LIN, KAI-HSIN; LIN, DONG-TSAMN; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2006-06 |
CYTOGENETICS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN TAIWAN: A Single-Institutional Experience
|
張修豪; 盧孟佑; 周獻堂; 林凱信; 林東燦; 田蕙芬; 林東燦 |
| 臺大學術典藏 |
2020-12-16T07:22:02Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Chang H.-H.;Meng-Yao Lu;Jou S.-T.;Lin K.-H.;Tien H.-F.;Lin D.-T.; Chang H.-H.; MENG-YAO LU; Jou S.-T.; Lin K.-H.; Tien H.-F.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-18T05:28:49Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Lin D.-T.; HSIU-HAO CHANG; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Tien H.-F.; Hsiu-Hao Chang;Lu M.-Y.;Jou S.-T.;Lin K.-H.;Tien H.-F.;Lin D.-T. |
| 臺大學術典藏 |
2021-01-04T12:12:56Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Chang H.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; HWEI-FANG TIEN; Lin D.-T. |
| 臺大學術典藏 |
2021-01-05T02:29:02Z |
Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: A single-institutional experience
|
Lin D.-T.; Tien H.-F.; Lin K.-H.; SHIANN-TANG JOU; Lu M.-Y.; Chang H.-H.; Chang H.-H.;Lu M.-Y.;Shiann-Tang Jou;Lin K.-H.;Tien H.-F.;Lin D.-T. |
| 國立臺灣大學 |
1994 |
Cytogenetics studies on Saccharum-Miscanthus Nobilization.
|
Cheng, H-H; Wen, Y-Y; Chen, C |
| 臺北醫學大學 |
2013 |
Cytogenic and molecular analyses of 46,XX male syndrome with clinical comparison to other groups with testicular azoospermia of genetic origin
|
Chiang, HS;Wu, YN;Wu, CC;Hwang, JL |
| 臺北醫學大學 |
2013 |
Cytogenic and molecular analyses of 46,XX male syndrome with clinical comparison to other groups with testicular azoospermia of genetic origin
|
HS, Chiang;YN, Wu;CC, Wu;JL, Hwang |
| 國家衛生研究院 |
2021-04-23 |
Cytoguardin: A tryptophan metabolite against cancer growth and metastasis
|
Wu, KK |
| 國家衛生研究院 |
2014-12-08 |
cytoHubba: Identifying hub objects and sub-networks from complex interactome
|
Chin, CH;Chen, SH;Wu, HH;Ho, CW;Ko, MT;Lin, CY |
| 東海大學 |
2011-04 |
Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
|
趙偉廷; Liu, Yi-Hsiang; Ho, Chin-Chin; Cheng, Chiung-Chi; Chao, Wei-Ting; Pei, Ren-Jeng; Hsu, Yung-Hsiang; Lai, Yih-Shyong |
| 高雄醫學大學 |
1996 |
Cytokeratin Fragment 19 (CYFRA 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer
|
黃明賢;鍾相彬;林茂生;鍾飲文;蔡米山;林秀純;黃吉志 ; Huang, MS;Jong, SB;Lin, MS;Chong, IW;Tsai, MS;Lin, HC;Hwang, JJ |
